A Study of RhinAer ARC Stylus for Treating Chronic Rhinitis (RELIEF)

Inclusion Criteria

• Age 18 to 85 years (inclusively).
• Willing and able to provide informed consent.
• Willing and able to comply with the subject-specific requirements outlined in the Study Protocol.
• Seeking treatment for chronic rhinitis symptoms of at least 6 months duration and willing to undergo an office-based procedure.
• Moderate to severe symptoms of rhinorrhea (rTNSS rating of 2 or 3 for rhinorrhea).
• Mild to severe symptoms of nasal congestion (rTNSS rating of 1, 2 or 3 for congestion).
• rTNSS ≥ 6.

Exclusion Criteria

• Anatomic obstructions that in the investigator's opinion limit access to the posterior nasal passage.
• Altered anatomy of the posterior nose as a result of prior sinus or nasal surgery or injury.
• Active nasal or sinus infection.
• History of significant dry eye.
• History of any of the following: chronic epistaxis, documented episodes of significant nose bleeds in the past 3 months, rhinitis medicamentosa, head or neck irradiation.
• Have rhinitis symptoms only on a seasonal basis due to allergies.
• Known or suspected allergies or contraindications to the anesthetic agents and/or antibiotic medications to be used during the study procedure session.
• Known or suspected to be pregnant or is lactating.
• Participating in another clinical research study.
• Has any condition that predisposes to excessive bleeding.
• Is taking anticoagulants (eg, warfarin, Plavix) or 325 mg aspirin that cannot be discontinued before the procedure.
• Has previous procedure or surgery for chronic rhinitis.
• Other medical conditions which in the opinion of the investigator would predispose the subject to poor wound healing, increased surgical risk, or poor compliance with the requirements of the study.